Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
83.74
+1.04 (1.26%)
At close: Oct 8, 2025, 4:00 PM EDT
82.07
-1.67 (-1.99%)
After-hours: Oct 8, 2025, 6:08 PM EDT
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $382.46M in the quarter ending June 30, 2025, with 13.15% growth. This brings the company's revenue in the last twelve months to $1.43B, up 10.11% year-over-year. In the year 2024, Merit Medical Systems had annual revenue of $1.36B with 7.89% growth.
Revenue (ttm)
$1.43B
Revenue Growth
+10.11%
P/S Ratio
3.43
Revenue / Employee
$193,624
Employees
7,400
Market Cap
4.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.36B | 99.15M | 7.89% |
Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
MMSI News
- 5 days ago - Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 - GlobeNewsWire
- 7 days ago - Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology - GlobeNewsWire
- 26 days ago - Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis - GlobeNewsWire
- 4 weeks ago - Merit Medical Has To Rebuild Some Confidence In The Growth Story - Seeking Alpha
- 7 weeks ago - First Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry - GlobeNewsWire
- 2 months ago - Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology - GlobeNewsWire
- 2 months ago - Merit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Merit Medical Names Martha Aronson as New President and Chief Executive Officer - GlobeNewsWire